Science Explorer Back to mapMap
Discussion
Researcher · Novocure (United States) · United States

Tal Kan

Tal Kan publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Cancer Research and Treatments, Immune cells in cancer and Nanoplatforms for cancer theranostics.

ORCID 0000-0002-9895-697X OpenAlex
World rank
#2,289,802
of 7,710,434 ranked researchers
Rank in United States
#683,493
of 1,627,098
Works
46
Citations
349
Citations per work
7.6
h-index
8
i10-index 8Top 85% in Immunology
Tal Kan

What does Tal Kan research?

Tal Kan's work is mostly in Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (24%), Medicine (16%).

Life Sciences: 22 works · 48.9% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 25.0% of their workMolecular Biology: 6 works · 13.6% of their workBiotechnology: 5 works · 11.4% of their workImmunology and Microbiology: 11 works · 23.9% of their workImmunology: 11 works · 23.9% of their workEverything else: 9 works · 19.3% of their workPhysical Sciences: 7 works · 15.9% of their workEngineering: 4 works · 9.1% of their workBiomedical Engineering: 4 works · 9.1% of their workMaterials Science: 3 works · 6.8% of their workBiomaterials: 3 works · 6.8% of their workHealth Sciences: 7 works · 15.9% of their workMedicine: 7 works · 15.9% of their workOncology: 7 works · 15.9% of their workTHEIR WORKTal Kan46works
Life Sciences49%Physical Sciences16%Health Sciences16%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1225.0%
    2. Immunology and Microbiology1123.9%
  2. Everything else919.3%
    1. Engineering49.1%
    2. Materials Science36.8%
    1. Medicine715.9%
  1. 1Immunology24% of their works
  2. 2Oncology16% of their works
  3. 3Molecular Biology14% of their works
  4. 4Biotechnology11% of their works
  5. 5Biomedical Engineering9% of their works
  6. 6Biomaterials7% of their works

Research topics

Which keywords describe Tal Kan's research?

The keywords of their largest research topics: Tumor Targeting, Immunotherapy, Immunity, Nanoparticles, Cancer, Arginine Deprivation, Bacterial Therapy and Activation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Tumor Targeting233 topics
  2. Immunotherapy172 topics
  3. Immunity142 topics
  4. Nanoparticles132 topics
  5. Cancer122 topics
  6. Arginine Deprivation101 topic
  7. Bacterial Therapy101 topic
  8. Activation91 topic
  9. Drug Delivery92 topics
  10. Macrophage91 topic
  11. Photothermal Therapy71 topic
  12. Reactive Oxygen Species71 topic
  13. Cancer Therapy61 topic
  14. Nanocarriers61 topic
  15. Cancer Immunotherapy51 topic
  16. Cancer Stem Cells51 topic
  17. Dendritic Cells51 topic
  18. Immune Checkpoint Blockade51 topic
  19. PD-1 and PD-L151 topic
  20. Tumor Metastasis51 topic
  21. Exosomes31 topic
  22. Extracellular Vesicles31 topic

Where does Tal Kan work?

Tal Kan's main affiliation in the publication record is Novocure (United States), United States.

How many publications and citations does Tal Kan have?

OpenAlex counts 46 works and 349 citations for Tal Kan, an h-index of 8, ranking #2,289,802 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Tal Kan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.